CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy

Abstract Background Anamorelin is expected to improve cancer cachexia by increasing lean body mass (LBM) due to increased appetite and protein synthesis. However, the effect of anamorelin on cancer cachexia in real-world practice is unclear. The purpose of this study was to evaluate the efficacy and...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Hironori Fujii, Akitaka Makiyama, Kayoko Nishimura, Hirotoshi Iihara, Chiemi Hirose, Koichi Ohata, Yunami Yamada, Daichi Watanabe, Itaru Yasufuku, Naoki Okumura, Yoshihiro Tanaka, Takao Takahashi, Ryo Kobayashi, Nobuhisa Matsuhashi, Akio Suzuki
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2024-07-01
סדרה:	Journal of Pharmaceutical Health Care and Sciences
נושאים:	Cancer cachexia Anamorelin CONUT score Survival Performance status
גישה מקוונת:	https://doi.org/10.1186/s40780-024-00359-5
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!